Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroto Hatakeyama

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 1, 2018
[Development of a Novel Liposomal DDS by Manipulating Pharmacokinetics and Intracellular Trafficking for Drug Therapy and Nucleic Acid Medicine]Hiroto Hatakeyama
Chemical & Pharmaceutical Bulletin|July 5, 2017
Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and TherapeuticsHiroto Hatakeyama
Biological & Pharmaceutical Bulletin|June 4, 2013
The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumorsHiroto Hatakeyama, Hidetaka Akita, Hideyoshi Harashima
Biological & Pharmaceutical Bulletin|July 8, 2010
Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cellsYusuke Sato, Hiroto Hatakeyama, Hideyoshi Harashima
International Journal of Pharmaceutics|March 19, 2011
A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand systemGolam Kibria, Hiroto Hatakeyama, Hideyoshi Harashima
Archives of Pharmacal Research|November 26, 2013
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery systemGolam Kibria, Hiroto Hatakeyama, Hideyoshi Harashima
Advanced Drug Delivery Reviews|September 16, 2010
A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemmaHiroto Hatakeyama, Hidetaka Akita, Hideyoshi Harashima
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 19, 2015
Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver CellsYusuke Sato, Hiroto Hatakeyama, Mamoru Hyodo, et al.
Advances in Biochemical Engineering/Biotechnology|April 4, 2009
A novel nonviral gene delivery system: multifunctional envelope-type nano deviceHiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid]Hiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 1, 2018
[Development of a Novel Liposomal DDS by Manipulating Pharmacokinetics and Intracellular Trafficking for Drug Therapy and Nucleic Acid Medicine]Hiroto Hatakeyama
Chemical & Pharmaceutical Bulletin|July 5, 2017
Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and TherapeuticsHiroto Hatakeyama
Biological & Pharmaceutical Bulletin|June 4, 2013
The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumorsHiroto Hatakeyama, Hidetaka Akita, Hideyoshi Harashima
Biological & Pharmaceutical Bulletin|July 8, 2010
Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cellsYusuke Sato, Hiroto Hatakeyama, Hideyoshi Harashima
International Journal of Pharmaceutics|March 19, 2011
A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand systemGolam Kibria, Hiroto Hatakeyama, Hideyoshi Harashima
Archives of Pharmacal Research|November 26, 2013
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery systemGolam Kibria, Hiroto Hatakeyama, Hideyoshi Harashima
Advanced Drug Delivery Reviews|September 16, 2010
A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemmaHiroto Hatakeyama, Hidetaka Akita, Hideyoshi Harashima
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 19, 2015
Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver CellsYusuke Sato, Hiroto Hatakeyama, Mamoru Hyodo, et al.
Advances in Biochemical Engineering/Biotechnology|April 4, 2009
A novel nonviral gene delivery system: multifunctional envelope-type nano deviceHiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid]Hiroto Hatakeyama, Hidetaka Akita, Kentaro Kogure, et al.
Pageof 8